Ardelyx Inc (ARDX)

NASDAQ
0.804
-0.042(-4.91%)
Pre Market
0.820
+0.016(+1.99%)
- Real-time Data
  • Volume:
    3,096,383
  • Bid/Ask:
    0.820/0.840
  • Day's Range:
    0.800 - 0.870

ARDX Overview

Prev. Close
0.845
Day's Range
0.8-0.87
Revenue
10.87M
Open
0.862
52 wk Range
0.75-9.19
EPS
-1.53
Volume
3,096,383
Market Cap
90.65M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
16,891,495
P/E Ratio
-
Beta
1.77
1-Year Change
-89.08%
Shares Outstanding
112,743,408
Next Earnings Date
08 Mar 2022
What is your sentiment on Ardelyx Inc?
or
Market is currently closed. Voting is open during market hours.

Ardelyx Inc Company Profile

Employees
129

Ardelyx, Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of medicines to improve treatment for people with kidney and cardiorenal diseases. The Company's product pipeline includes Tenapanor, IBSRELA, RDX013 Program, and RDX020 Program. The Tenapanor is a medicine for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor for the control of serum phosphorus has a mechanism of action and acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3). IBSRELA is developed for the treatment of patients with irritable bowel syndrome with constipation (IBS-C). RDX013 Program is a small molecule potassium secretagogue program for the potential treatment of hyperkalemia. RDX020 Program is a small molecule for treating metabolic acidosis. It has a discovery program targeting the inhibition of intestinal bicarbonate exchange for the treatment of metabolic acidosis.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.